Telix Pharmaceuticals And 2 Other Australian Insider Owned Growth Stocks

AI spending is racing ahead even as interest rates stay high, which is putting a premium on businesses that can fund growth from the inside rather than relying heavily on markets. That is where fast growing Australian stocks with large insider stakes become interesting. Management has meaningful skin in the game, and the balance of risk and reward can look very different. This article highlights three such opportunities from our screener.

The three stocks highlighted here offer a compelling starting point if you want exposure to fast growing businesses where insiders are heavily aligned with shareholders. However, if you want the names that matter most, these 27 high growth high conviction stocks are the strongest companies we've found.

Telix Pharmaceuticals (ASX:TLX)

Telix Pharmaceuticals ties closely to the Fast Growing Stocks With High Insider Ownership theme because its late stage radiopharmaceutical pipeline and commercial prostate cancer imaging products give analysts and management specific clinical milestones and revenue streams to focus their optimism on.

Telix Pharmaceuticals develops and sells radiopharmaceutical diagnostics and therapies, with most revenue coming from Precision Medicine at about US$704 million and Manufacturing Solutions contributing roughly US$277 million, and the stock valued at around A$5.3 billion by market cap.

Telix attracts growth focused investors because late stage radiopharmaceutical products such as TLX591 and Illuccix link a clear medical need with a commercially proven platform that insiders are heavily backing.

"Their primary revenue generating imaging agents: 'Illuccix' and 'Gozellix', are utilised in 23+ countries worldwide, including key markets such as the U.S, Europe, China and Japan, with revenue figures of $803.8m (USD) in the 2025 Financial Year (within their already upgraded guidance range) provided for FY25, a cash balance of $141.9m (USD), and the potential growth of Gozellix as its launch into the U.S expands."

What really matters now is how one unresolved pressure in the background shapes future pricing power and overall earnings quality.

That pressure point is exactly where the full narrative for Telix Pharmaceuticals connects the clinical story to pricing power, cash durability and how Telix Pharmaceuticals insiders are positioned if sentiment swings hard.

Codan (ASX:CDA)

Codan is picked up by this Fast Growing Stocks With High Insider Ownership theme because its metal detection arm gives management a clear, growth focused lever in gold and security markets, even as the broader group still earns most revenue from communications technology.

Codan develops communications gear and metal detectors worldwide, generating about A$506 million from Communications and A$362 million from Metal Detection, with a smaller unallocated slice, and the business valued at roughly A$11.4b by market cap.

For this screener, Codan matters as a technology group where management is leaning into high demand uses of its hardware, especially in areas tied to security, gold detection and unmanned systems, and that combination of momentum and conviction is what the growth focused screen is looking to capture.

"Heightened geopolitical tensions, increased defense spending, and the need for resilient communications infrastructure, especially in light of remilitarization and growing demand for unmanned systems, are expanding Codan's customer base and forward order book in defense and public safety, driving both near-term and long-term revenue growth."

What could really shift the Codan story now is how one hard to predict swing factor influences both pricing power and the durability of that earnings trajectory investors are currently paying up for.

That swing factor is exactly what the full narrative for Codan unpacks, separating cyclical noise from the forces that could keep Codan's communications and detection engine accelerating.

Southern Cross Electrical Engineering (ASX:SXE)

Southern Cross Electrical Engineering builds and maintains complex electrical, communications and fire systems, with a growing focus on decarbonization projects that fit the Fast Growing Stocks With High Insider Ownership theme. It generated about A$718.7 million from electrical, security and communication services in Australia and has a market value near A$1.4 billion.

Southern Cross Electrical Engineering taps directly into the growth theme here because it pairs traditional electrical work with renewables, grid connections and heavy electrification for lithium and copper projects, giving management a clear runway to chase larger, longer duration energy-transition work.

"The company sits downstream of powerful structural drivers: AI workloads, cloud migration, enterprise digitalisation, and data sovereignty requirements, all of which are driving sustained demand for data centre capacity."

What really matters now is how one unresolved pressure in project timing and execution shapes both earnings quality and the durability of that growth story.

Those project risks are exactly where the full narrative for Southern Cross Electrical Engineering shows how Southern Cross Electrical Engineering could convert timing volatility into accelerating earnings power and potentially stronger investor conviction.

Curious About What You Might Be Missing?

Fresh opportunities can move fast. Some are building breakout momentum, others quietly moving into value territory under the radar for now. Scan the field before the crowd and review ideas that may fit your strategy.

• Target reliable income streams before yields change with a curated pool of 4 dividend fortresses that aim to keep cash flow front and center.
• Look for resilient balance sheets with a focused list of solid balance sheet and fundamentals (12 results) built with durability in mind.
• Explore the infrastructure supporting AI demand by screening through 55 AI infrastructure stocks designed for long operational runways.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com